Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy.
American Journal of Nephrology.
Times cited: 319
Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL).
Times cited: 179